HENNEPIN HEALTHCARE RESEARCH INSTITUTE

• UNIVERSITY OF MONTANA

  UEI DAY7Z8ZD48Q3 · not in the directory yet

  $1M

  Subcontractor to this prime · 1 sub-award · latest Apr 18, 2025

  • National Institutes of Health
  • “THE PURPOSE OF STUDIES AT THE HENNEPIN HEALTHCARE RESEARCH INSTITUTE (HHRI) SITE IS TO TEST LEAD VACCINES TARGETING HEROIN AND FENTANYL FOR THEIR ABILITY TO REDUCE THE ADDICTIVE EFFECTS OF THESE DRUGS IN RATS. IN ADDITION, HHRI WILL EXAMINE WHETHER COMBINING THESE VACCINES INTO A BIVALENT FORMULATION WILL ALTER THEIR EFFICACY. THE WORK REQUIRED TO ACCOMPLISH THIS INVOLVES A SERIES OF FIVE STUDIES IN WHICH THE EFFECTS OF VACCINATION ON HEROIN AND FENTANYL SELF-ADMINISTRATION AND WITHDRAWAL WILL BE EXAMINED IN RATS. THE FIRST EXPERIMENT WILL TEST THE EFFICACY OF A LEAD HEROIN AND BIVALENT VACCINE AT REDUCING HEROIN SELF-ADMINISTRATION (HSA). THE SECOND EXPERIMENT WILL TEST THE EFFICACY OF A LEAD FENTANYL AND BIVALENT VACCINE AT REDUCING FENTANYL SELF-ADMINISTRATION (FSA). THE THIRD EXPERIMENT WILL TEST THE EFFICACY OF THE BIVALENT VACCINE AT REDUCING COCAINE SELFADMINISTRATION TO CONFIRM THE BEHAVIORAL SPECIFICITY OF THE VACCINE. THE FOURTH AND FIFTH EXPERIMENTS WILL TEST WHETHER THE BIVALENT VACCINE PRECIPITATES HEROIN OR FENTANYL WITHDRAWAL, RESPECTIVELY, USING AN INTRACRANIAL SELF-STIMULATION ASSAY.”
• UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

  UEI MKAGLD59JRL1

  $620.2K

  Subcontractor to this prime · 1 sub-award · latest Sep 12, 2025

  • Defense Health Agency
  • “NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL”
• VANDERBILT UNIVERSITY MEDICAL CENTER

  UEI GYLUH9UXHDX5

  $535K

  Subcontractor to this prime · 1 sub-award · latest Jul 22, 2024

  • Centers for Disease Control and Prevention
  • “IVY 5 - SURVEILLANCE OF ACUTELY ILL ADULTS WITH RESPIRATORY VIRUSES, INCLUDING SARS-COV-2”
• AMERICAN INSTITUTES FOR RESEARCH IN THE BEHAVIORAL SCIENCES

  UEI MCN6J5L6M3T4

  $155K

  Subcontractor to this prime · 1 sub-award · latest Sep 22, 2026

  • Centers for Medicare and Medicaid Services
  • “DURING THE BASE PERIOD OF THIS CONTRACT, HHRI WILL PROVIDE CONSULTATION AND SUPPORT FOR ACTIVITIES AND DELIVERABLES DESCRIBED IN THE CMS SOW. WE NEXT DESCRIBE SPECIFIC ACTIVITIES AND DELIVERABLES FOR ALL RELEVANT TASKS. EACH TASK SPECIFIED BY CMS SHALL INCLUDE ONE OR MORE SUBTASKS TO ACCOMPLISH THE EVALUATION OF THE INCREASING ORGAN ACCESS TRANSPLANT (IOTA) MODEL (IOTA EVALUATION) PROGRAM EFFORTS. WE LIST SPECIFIC DELIVERABLES AND ACTIVITIES FOR HHRI TO PROVIDE CONSULTATION AND TECHNICAL INPUT, AND MAY REQUEST ADDITIONAL SUPPORT, AS NECESSARY.”

No reported sub-awards as a prime contractor.

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.